The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 12, 2023

Filed:

Apr. 11, 2017
Applicant:

Gw Research Limited, Cambridge, GB;

Inventors:

Geoffrey Guy, Cambridge, GB;

Stephen Wright, Cambridge, GB;

James Brodie, Cambridge, GB;

Marie Woolley-Roberts, Cambridge, GB;

Rafael Maldonado, Barcelona, ES;

Daniela Parolaro, Varese, IT;

Livio Luongo, Naples, IT;

Joanna Neill, Manchester, GB;

Assignee:

GW RESEARCH LIMITED, Cambridge, GB;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/05 (2006.01); A61K 36/185 (2006.01); A61K 45/06 (2006.01); A61K 31/352 (2006.01); A61P 25/28 (2006.01); A61P 25/18 (2006.01); A61K 36/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/05 (2013.01); A61K 31/352 (2013.01); A61K 36/185 (2013.01); A61K 45/06 (2013.01); A61P 25/18 (2018.01); A61P 25/28 (2018.01);
Abstract

The present invention relates to the use of cannabidivarin (CBDV) in the treatment of autism spectrum disorder (ASD) and ASD-associated disorders such as Fragile X syndrome (FXS); Rett syndrome (RS); or Angelman syndrome (AS). In a further embodiment the invention relates to the use of CBDV in the treatment of schizophrenia. CBDV has been shown to be particularly effective in improving cognitive dysfunction in rodent models of ASD, FXS, RS, AS and schizophrenia. The CBDV is preferably substantially pure. It may take the form of a highly purified extract ofsuch that the CBDV is present at greater than 95% of the total extract (w/w) and the other components of the extract are characterised. Alternatively, the CBDV is synthetically produced.


Find Patent Forward Citations

Loading…